GlaxoSmithKline, Theravance Combined Drug for COPD Shows Postitive Results – FOXBusiness


Proactive Investors USA & Canada

GlaxoSmithKline, Theravance Combined Drug for COPD Shows Postitive Results
FOXBusiness
Wednesday that their combined treatment for patients with chronic obstructive pulmonary disorder and asthma posted strong results in a clinical study.
Glaxo, Theravance report Relovair safety dataBusinessWeek
GSK and Theravance announce combination ICS/LABA Phase II results in the MarketWatch (press release)
GlaxoSmithKline and Theravance announce positive phase II results for Relovair Proactive Investors USA & Canada
FierceBiotech –RTT News
all 38 news articles »

View full post on asthma – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *